share_log

6-K: Report of foreign private issuer (related to financial reporting)

6-K: Report of foreign private issuer (related to financial reporting)

6-K:外国发行人报告(业绩相关)
美股SEC公告 ·  2024/07/29 14:19

Moomoo AI 已提取核心信息

Lilium N.V., a foreign private issuer, has reported to the U.S. Securities and Exchange Commission (SEC) that it has entered into an At Market Issuance Sales Agreement with B. Riley Securities, Inc. on July 26, 2024. Under this agreement, Lilium may offer and sell up to $100 million of its Class A ordinary shares. The initial offering of up to $33 million will be under the company's shelf registration statement on Form F-3, effective since October 12, 2022, with the remaining $67 million subject to SEC approval of a new registration statement. Sales will be conducted as 'at the market offerings,' and B. Riley will receive a commission for its services. The agreement includes customary indemnification rights and reimbursement of certain expenses for B...Show More
Lilium N.V., a foreign private issuer, has reported to the U.S. Securities and Exchange Commission (SEC) that it has entered into an At Market Issuance Sales Agreement with B. Riley Securities, Inc. on July 26, 2024. Under this agreement, Lilium may offer and sell up to $100 million of its Class A ordinary shares. The initial offering of up to $33 million will be under the company's shelf registration statement on Form F-3, effective since October 12, 2022, with the remaining $67 million subject to SEC approval of a new registration statement. Sales will be conducted as 'at the market offerings,' and B. Riley will receive a commission for its services. The agreement includes customary indemnification rights and reimbursement of certain expenses for B. Riley. The agreement may be terminated by either party and will automatically end upon the sale of all shares or as permitted within the agreement. This move is part of Lilium's strategic plan to fund operations until the type certification and entry into service of its products, considering both dilutive and non-dilutive financing methods, and exploring strategic opportunities, including joint ventures and partnerships. The company has clarified tax considerations in its annual report and incorporated the contents of this report into its previous SEC filings.
外国私募发行人Lilium N.V.向美国证券交易委员会(SEC)报告,其已于2024年7月26日与b. Riley Securities, Inc.签署了一项按市场发行销售协议。根据该协议,Lilium可以将其A类普通股发售高达1亿美元。最初的发售额高达3300万美元,将在公司于2022年10月12日生效的F-3表格上的货架注册声明下进行,其余的6700万美元则须获得SEC的新注册声明批准。销售将作为“在市场发行”的形式进行,并且b. Riley将获得其服务的佣金。协议包括惯例赔偿权利和补偿b. Riley某些费用。任何一方均可终止协议,而协议将在出售所有股份或在协议允许的范围内自动终止。此举是Lilium战略计划的一部分,以资助其产品获得型号认证并进入役,考虑到稀释和非稀释融资方法,并探索联合企业和合作机会。公司已在其年度报告中澄清了税务问题,并将此报告内容并入其之前的SEC申报文件中。
外国私募发行人Lilium N.V.向美国证券交易委员会(SEC)报告,其已于2024年7月26日与b. Riley Securities, Inc.签署了一项按市场发行销售协议。根据该协议,Lilium可以将其A类普通股发售高达1亿美元。最初的发售额高达3300万美元,将在公司于2022年10月12日生效的F-3表格上的货架注册声明下进行,其余的6700万美元则须获得SEC的新注册声明批准。销售将作为“在市场发行”的形式进行,并且b. Riley将获得其服务的佣金。协议包括惯例赔偿权利和补偿b. Riley某些费用。任何一方均可终止协议,而协议将在出售所有股份或在协议允许的范围内自动终止。此举是Lilium战略计划的一部分,以资助其产品获得型号认证并进入役,考虑到稀释和非稀释融资方法,并探索联合企业和合作机会。公司已在其年度报告中澄清了税务问题,并将此报告内容并入其之前的SEC申报文件中。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息